Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07549399 Cetuximab Rectal Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07549399 clinical trial report covering Cetuximab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07551492 Ribupatide Atherosclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07551492 clinical trial report covering Ribupatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261636 Interferon alpha-2b(Anhui Anke Biotechnology) Herpangina Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261636 clinical trial report covering Interferon alpha-2b(Anhui Anke Biotechnology), Phase 3, endpoints, sponsor, geography, readout timing and developme
Latest Hotspot
8 min read
NCT07552389 HL-1113 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07552389 clinical trial report covering HL-1113, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07553182 Filgotinib Maleate Juvenile Idiopathic Arthritis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07553182 clinical trial report covering Filgotinib Maleate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07552597 Technetium (99mTc) Pyrophosphate Melanoma, Cutaneous Malignant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07552597 clinical trial report covering Technetium (99mTc) Pyrophosphate, Phase 3, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
CTR20261498 Octreotide(CSPC Zhongqi) Acromegaly Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261498 clinical trial report covering Octreotide(CSPC Zhongqi), Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07552987 Immune Globulin Intravenous, Human -kthm (Kedrion) Stiff-Person Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07552987 clinical trial report covering Immune Globulin Intravenous, Human -kthm (Kedrion), Phase 3, endpoints, sponsor, geography, readout timing and deve
Latest Hotspot
8 min read
NCT07553286 Cetylpyridinium Chloride Hydrate Periodontal Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07553286 clinical trial report covering Cetylpyridinium Chloride Hydrate, Phase 3, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
CTR20261336 Indacaterol Acetate/Mometasone Furoate Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261336 clinical trial report covering Indacaterol Acetate/Mometasone Furoate, Phase 3, endpoints, sponsor, geography, readout timing and development whit
Latest Hotspot
8 min read
ChiCTR2600123580 Dexamethasone Sodium Phosphate Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600123580 clinical trial report covering Dexamethasone Sodium Phosphate, Phase 3, endpoints, sponsor, geography, readout timing and development white s
Latest Hotspot
8 min read
ChiCTR2600123594 Adebrelimab Non-squamous non-small cell lung cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600123594 clinical trial report covering Adebrelimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.